ѻý

<ѻý class="page-title">Spotlight On

Myelofibrosis

<ѻý class="page-description">

More in Myelofibrosis

Myelofibrosis: Beyond Ruxolitinib

Other JAK inhibitors, combinations, and novel therapies offer more hope for patients

Jun 07, 2024
A computer rendering of myelofibrosis cells in the blood.
Undergoing Stem Cell Transplant for Myelofibrosis

The procedure offers a potential cure, but comes with a risk of early morbidity and mortality

May 22, 2024
A computer rendering of stem cells.
Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management

Genetics already informs prognosis, may help guide therapy development beyond JAK2 inhibition

May 01, 2024
A photo of a lab technician using a pipette to transfer a sample to a multi well plate in a laboratory.
Myelofibrosis: A Rare Malignancy Attracting More and More Attention

Increased interest follows mutation discoveries, development of targeted therapies

May 01, 2024
A computer rendering of Myelofibrosis cells in the blood

1.00 CME Credits
Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA)

0.50 CME Credits
Overcoming Obstacles to Quality Care for Psoriasis Patients in Rural Communities: Key Insights From a Project ECHO Initiative

0.50 CME Credits
Breaking Through Barriers to Achieving Optimal Outcomes for Psoriatic Arthritis Patients in Rural Communities: Key Takeaways From a Project ECHO Initiative

0.25 CME Credits
Leveraging the Latest Data to Guide Precision Medicine in Rheumatoid Arthritis

0.50 CME Credits
Developing Patient-Centered Approaches to Optimize the Management of Bipolar I Disorder

0.50 CME Credits
Integrating Current and Emerging Evidence on Bipolar I Disorder to Personalize Patient Care

2.00 CME Credits
Appropriate Healthcare Interventions in Elder, Child, and Intimate Partner Abuse

3.00 CME Credits
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain